Phytopharmacological Overview of Psidium Guajava Linn
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Phytochemical Analysis and Antimicrobial Activity of Myrcia Tomentosa (Aubl.) DC
molecules Article Phytochemical Analysis and Antimicrobial Activity of Myrcia tomentosa (Aubl.) DC. Leaves Fabyola Amaral da Silva Sa 1,3, Joelma Abadia Marciano de Paula 2, Pierre Alexandre dos Santos 3, Leandra de Almeida Ribeiro Oliveira 3, Gerlon de Almeida Ribeiro Oliveira 4, Luciano Morais Liao 4 , Jose Realino de Paula 3,* and Maria do Rosario Rodrigues Silva 1,* 1 Institute of Tropical Pathology and Public Health, Federal University of Goias, Goiânia 74605-050, Brazil; [email protected] 2 Unit of Exact and Technologic Sciences, Goias State University, Anápolis 75132-400, Brazil; [email protected] 3 Faculty of Pharmacy, Federal University of Goias, Goiânia 74605-170, Brazil; [email protected] (P.A.d.S.); [email protected] (L.d.A.R.O.) 4 Chemistry Institute, Federal University of Goiás, Goiânia 74690-900, Brazil; [email protected] (G.d.A.R.O.); [email protected] (L.M.L.) * Correspondence: [email protected] (J.R.d.P.); [email protected] (M.d.R.R.S.); Tel.: +55-62-3209-6127 (M.d.R.R.S.); Fax: +55-62-3209-6363 (M.d.R.R.S.) Academic Editor: Isabel C. F. R. Ferreira Received: 23 May 2017; Accepted: 29 June 2017; Published: 4 July 2017 Abstract: This work describes the isolation and structural elucidation of compounds from the leaves of Myrcia tomentosa (Aubl.) DC. (goiaba-brava) and evaluates the antimicrobial activity of the crude extract, fractions and isolated compounds against bacteria and fungi. Column chromatography was used to fractionate and purify the extract of the M. tomentosa leaves and the chemical structures of the compounds were determined using spectroscopic techniques. -
Guava (Psidium Guajava L.) Leaves: Nutritional Composition, Phytochemical Profile, and Health-Promoting Bioactivities
foods Review Guava (Psidium guajava L.) Leaves: Nutritional Composition, Phytochemical Profile, and Health-Promoting Bioactivities Manoj Kumar 1 , Maharishi Tomar 2, Ryszard Amarowicz 3,* , Vivek Saurabh 4 , M. Sneha Nair 5, Chirag Maheshwari 6, Minnu Sasi 7, Uma Prajapati 4, Muzaffar Hasan 8, Surinder Singh 9, Sushil Changan 10 , Rakesh Kumar Prajapat 11, Mukesh K. Berwal 12 and Varsha Satankar 13 1 Chemical and Biochemical Processing Division, ICAR—Central Institute for Research on Cotton Technology, Mumbai 400019, India; [email protected] 2 ICAR—Indian Grassland and Fodder Research Institute, Jhansi 284003, India; [email protected] 3 Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Tuwima 10 Str., 10-748 Olsztyn, Poland 4 Division of Food Science and Postharvest Technology, ICAR—Indian Agricultural Research Institute, New Delhi 110012, India; [email protected] (V.S.); [email protected] (U.P.) 5 Department of Nutrition and Dietetics, Faculty of Allied Health Sciences, Manav Rachna International Institute of Research and Studies, Faridabad 121004, Haryana, India; [email protected] 6 Department of Agriculture Energy and Power, ICAR—Central Institute of Agricultural Engineering, Bhopal 462038, India; [email protected] 7 Division of Biochemistry, ICAR—Indian Agricultural Research Institute, New Delhi 110012, India; [email protected] 8 Agro Produce Processing Division, ICAR—Central Institute of Agricultural Engineering, Citation: Kumar, M.; Tomar, M.; Bhopal 462038, India; [email protected] 9 Amarowicz, R.; Saurabh, V.; Nair, Dr. S.S. Bhatnagar University Institute of Chemical Engineering and Technology, Panjab University, Chandigarh 160014, India; [email protected] M.S.; Maheshwari, C.; Sasi, M.; 10 Division of Crop Physiology, Biochemistry and Post-Harvest Technology, ICAR—Central Potato Research Prajapati, U.; Hasan, M.; Singh, S.; Institute, Shimla 171001, India; [email protected] et al. -
The Phytochemistry of Cherokee Aromatic Medicinal Plants
medicines Review The Phytochemistry of Cherokee Aromatic Medicinal Plants William N. Setzer 1,2 1 Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL 35899, USA; [email protected]; Tel.: +1-256-824-6519 2 Aromatic Plant Research Center, 230 N 1200 E, Suite 102, Lehi, UT 84043, USA Received: 25 October 2018; Accepted: 8 November 2018; Published: 12 November 2018 Abstract: Background: Native Americans have had a rich ethnobotanical heritage for treating diseases, ailments, and injuries. Cherokee traditional medicine has provided numerous aromatic and medicinal plants that not only were used by the Cherokee people, but were also adopted for use by European settlers in North America. Methods: The aim of this review was to examine the Cherokee ethnobotanical literature and the published phytochemical investigations on Cherokee medicinal plants and to correlate phytochemical constituents with traditional uses and biological activities. Results: Several Cherokee medicinal plants are still in use today as herbal medicines, including, for example, yarrow (Achillea millefolium), black cohosh (Cimicifuga racemosa), American ginseng (Panax quinquefolius), and blue skullcap (Scutellaria lateriflora). This review presents a summary of the traditional uses, phytochemical constituents, and biological activities of Cherokee aromatic and medicinal plants. Conclusions: The list is not complete, however, as there is still much work needed in phytochemical investigation and pharmacological evaluation of many traditional herbal medicines. Keywords: Cherokee; Native American; traditional herbal medicine; chemical constituents; pharmacology 1. Introduction Natural products have been an important source of medicinal agents throughout history and modern medicine continues to rely on traditional knowledge for treatment of human maladies [1]. Traditional medicines such as Traditional Chinese Medicine [2], Ayurvedic [3], and medicinal plants from Latin America [4] have proven to be rich resources of biologically active compounds and potential new drugs. -
Phenolic Compounds from Five Ericaceae Species Leaves and Their Related Bioavailability and Health Benefits
molecules Review Phenolic Compounds from Five Ericaceae Species Leaves and Their Related Bioavailability and Health Benefits 1,2 2, 1,3 1, Bianca Eugenia S, tefănescu , Katalin Szabo * , Andrei Mocan and Gianina Cri¸san * 1 Department of Pharmaceutical Botany, “Iuliu Hat, ieganu” University of Medicine and Pharmacy, 23, Ghe. Marinescu Street, 400337 Cluj-Napoca, Romania; [email protected] (B.E.S, .); [email protected] (A.M.) 2 Institute of Life Sciences, University of Agricultural Sciences and Veterinary Medicine, Cluj-Napoca, CaleaMănă¸stur3-5, 400372 Cluj-Napoca, Romania 3 Laboratory of Chromatography, Institute of Advanced Horticulture Research of Transylvania, University of Agricultural Sciences and Veterinary Medicine, 400372 Cluj-Napoca, Romania * Correspondence: [email protected] (K.S.); [email protected] (G.C.) Received: 13 April 2019; Accepted: 22 May 2019; Published: 29 May 2019 Abstract: Some species of the Ericaceae family have been intensively studied because of the beneficial health impact, known since ancient times, of their chemical components. Since most studies focus on the effects of fruit consumption, this review aims to highlight the phenolic components present in the leaves. For this purpose, five species from Ericaceae family (bilberry—Vaccinium myrtillus L., lingonberry—V. vitis-idaea L., bog bilberry—V. uliginosum L., blueberry—V. corymbosum L. and bearberry—Arctostapylos uva-ursi L.) were considered, four of which can be found in spontaneous flora. The chemical composition of the leaves revealed three major phenolic compounds: chlorogenic acid, quercetin and arbutin. The health promoting functions of these compounds, such as antioxidant and anti-inflammatory properties that could have preventive effects for cardiovascular disease, neurodegenerative disorders, cancer, and obesity, have been exemplified by both in vitro and in vivo studies in this review. -
In Silico Approach of Potential Phytochemical Inhibitor From
In Silico Approach of Potential Phytochemical Inhibitor from Moringa oleifera, Cocos nucifera, Allium cepa, Psidium guajava, and Eucalyptus globulus for the treatment of COVID-19 by Molecular Docking Ika Nur Fitriani ( [email protected] ) Universitas Islam Negeri Walisongo Semarang Wiji Utami Universitas Islam Negeri Sulthan Thaha Saifuddin Jambi Adi Tiara Zikri Universitas Gadjah Mada Pugoh Santoso Kinki Daigaku Kyushu Tanki Daigaku Research Keywords: covid-19, in-silico, molecular docking, Moringa oleifera, Allium cepa, Cocos nucifera, Psidium guajava, Eucalyptus globulus Posted Date: July 23rd, 2020 DOI: https://doi.org/10.21203/rs.3.rs-42747/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/25 Abstract Background Coronavirus disease 2019 (COVID-19) is caused by infection with severe acute respiratory syndrome coronavirus 2. COVID-19 has devastating effects on people in all countries and getting worse. We aim to investigate an in-silico docking analysis of phytochemical compounds from medicinal plants that used to combat inhibition of the COVID-19 pathway. There are several phytochemicals in medicinal plants, however, the mechanism of bioactive compounds remains unclear. These results are obtained from in silico research provide further information to support the inhibition of several phytochemicals. Methods Molecular docking used to determine the best potential COVID-19 M pro inhibitor from several bioactive compounds in Moringa oleifera, Allium cepa, Cocos nucifera, Psidium guajava, and Eucalyptus globulus. Molecular docking was conducted and scored by comparison with standard drugs remdesivir. ADME properties of selected ligands were evaluated using the Lipinski Rule. The interaction mechanism of the most recommended compound predicted using the STITCH database. -
Fireweed (Epilobium Angustifolium L.): Botany, Phytochemistry and Traditional Uses
DOI: 10.2478/hepo-2018-000 International journal edited by the Institute of Natural Fibres and Medicinal Plants Vol. 65 No. 3 2019 Received: 2019-08-01 DOI: 10.2478/hepo-2019-0018 DOI: 10.2478/hepo-2018-000 Accepted: 2019-09-20 Available online: 2019-09-30 REVIEW PAPER Fireweed (Epilobium angustifolium L.): botany, phytochemistry and traditional uses. A review ARTUR ADAMCZAK1*, MARIOLA DREGER2, KATARZYNA SEIDLER-ŁOŻYKOWSKA1, KAROLINA WIELGUS2 1Department of Botany, Breeding and Agricultural Technology of Medicinal Plants Institute of Natural Fibres and Medicinal Plants Kolejowa 2 62-064 Plewiska, Poland 2Department of Biotechnology Institute of Natural Fibres and Medicinal Plants Wojska Polskiego 71B 60-630 Poznań, Poland *corresponding author: phone: +48 (61) 665-95-50, e-mail: [email protected] Summary Fireweed (Epilobium angustifolium L., Onagraceae) is one of important medicinal plants used especially in the treatment of urogenital disorders, including benign prostatic hyperplasia (BPH) and prostatitis. The therapeutic effects of E. angustifolium extracts comprise antiproliferative, anti-inflammatory, immunomod- ulatory, antioxidant, and also antimicrobial activities. The aim of the present review was to provide the in- formation on the botany, phytochemistry and traditional uses of E. angustifolium. This plant is a widespread circumboreal species of North America and Eurasia, tolerant in terms of habitat conditions, and often oc- cupying man-made open habitats. Phytochemical studies on E. angustifolium resulted in the identification of about 250 different metabolites, including about 170 substances found for the first time in this plant in the last six years (2014–2019). Fireweed has an abundance of polyphenolic compounds, particularly ellagi- tannins. -
WO 2018/002916 Al O
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2018/002916 Al 04 January 2018 (04.01.2018) W !P O PCT (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every C08F2/32 (2006.01) C08J 9/00 (2006.01) kind of national protection available): AE, AG, AL, AM, C08G 18/08 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (21) International Application Number: DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, PCT/IL20 17/050706 HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, (22) International Filing Date: KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, 26 June 2017 (26.06.2017) MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (25) Filing Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, (26) Publication Language: English TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: (84) Designated States (unless otherwise indicated, for every 246468 26 June 2016 (26.06.2016) IL kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, (71) Applicant: TECHNION RESEARCH & DEVEL¬ UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, OPMENT FOUNDATION LIMITED [IL/IL]; Senate TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, House, Technion City, 3200004 Haifa (IL). -
Planta Medica Journal of Medicinal Plant and Natural Product Research
www.thieme.de/fz/plantamedica l www.thieme-connect.com/ejournals Planta Medica Journal of Medicinal Plant and Natural Product Research Editor-in-Chief Advisory Board Publishers Luc Pieters, Antwerp, Belgium Georg Thieme Verlag KG John T. Arnason, Ottawa, Canada Stuttgart · New York Yoshinori Asakawa, Tokushima, Japan Rüdigerstraße 14 Senior Editor Lars Bohlin, Uppsala, Sweden D-70469 Stuttgart Adolf Nahrstedt, Münster, Germany Mark S. Butler, S. Lucia, Australia Postfach 30 11 20 João Batista Calixto, Florianopolis, Brazil D-70451 Stuttgart Claus Cornett, Copenhagen, Denmark Review Editor Hartmut Derendorf, Gainesville, USA Thieme Publishers Matthias Hamburger, Basel, Switzerland Alfonso Garcia-Piñeres, Frederick MD, USA 333 Seventh Avenue Jürg Gertsch, Zürich, Switzerland New York, NY 10001, USA Simon Gibbons, London, UK www.thieme.com Editors De-An Guo, Shanghai, China Rudolf Bauer, Graz, Austria Andreas Hensel, Münster, Germany Veronika Butterweck, Muttenz, Kurt Hostettmann, Geneva, Switzerland Switzerland Peter J. Houghton, London, UK Thomas Efferth, Mainz, Germany Ikhlas Khan, Oxford MS, USA Irmgard Merfort, Freiburg, Germany Jinwoong Kim, Seoul, Korea Hermann Stuppner, Innsbruck, Austria Wolfgang Kreis, Erlangen, Germany Yang-Chang Wu, Taichung, Taiwan Roberto Maffei Facino, Milan, Italy Andrew Marston, Bloemfontein, South Africa Editorial Offices Matthias Melzig, Berlin, Germany Claudia Schärer, Basel, Switzerland Eduardo Munoz, Cordoba, Spain Tess De Bruyne, Antwerp, Belgium Nicholas H. Oberlies, Greensboro NC, USA Nigel B. Perry, -
Structural Requirements of Flavonoids and Related Compounds for Aldose Reductase Inhibitory Activity
788 Chem. Pharm. Bull. 50(6) 788—795 (2002) Vol. 50, No. 6 Structural Requirements of Flavonoids and Related Compounds for Aldose Reductase Inhibitory Activity Hisashi MATSUDA, Toshio MORIKAWA, Iwao TOGUCHIDA, and Masayuki YOSHIKAWA* Kyoto Pharmaceutical University; Misasagi, Yamashina-ku, Kyoto 607–8412, Japan. Received January 15, 2002; accepted February 13, 2002 The methanolic extracts of several natural medicines and medicinal foodstuffs were found to show an in- hibitory effect on rat lens aldose reductase. In most cases, flavonoids were isolated as the active constituents by 5 bioassay-guided separation, and among them, quercitrin (IC50 0.15 mM), guaijaverin (0.18 mM), and desmanthin- 1 (0.082 mM) exhibited potent inhibitory activity. Desmanthin-1 showed the most potent activity, which was equiv- alent to that of a commercial synthetic aldose reductase inhibitor, epalrestat (0.072 mM). In order to clarify the structural requirements of flavonoids for aldose reductase inhibitory activity, various flavonoids and related com- pounds were examined. The results suggested the following structural requirements of flavonoid: 1) the flavones and flavonols having the 7-hydroxyl and/or catechol moiety at the B ring (the 39,49-dihydroxyl moiety) exhibit the strong activity; 2) the 5-hydroxyl moiety does not affect the activity; 3) the 3-hydroxyl and 7-O-glucosyl moieties reduce the activity; 4) the 2–3 double bond enhances the activity; 5) the flavones and flavonols having the cate- chol moiety at the B ring exhibit stronger activity than those having the pyrogallol moiety (the 39,49,59-trihy- droxyl moiety). Key words aldose reductase inhibitor; flavonoid; structural requirement; desmanthin-1; quercitrin; guaijaverin Aldose reductase as a key enzyme in the polyol pathway is aerial parts of Centella asiatica (Umbelliferae),11) and the reported to catalyze the reduction of glucose to sorbitol. -
Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Tuberculosis
Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Tuberculosis Chemical Activity Count (+)-3-HYDROXY-9-METHOXYPTEROCARPAN 1 (+)-8HYDROXYCALAMENENE 1 (+)-ALLOMATRINE 1 (+)-ALPHA-VINIFERIN 3 (+)-AROMOLINE 1 (+)-CASSYTHICINE 1 (+)-CATECHIN 10 (+)-CATECHIN-7-O-GALLATE 1 (+)-CATECHOL 1 (+)-CEPHARANTHINE 1 (+)-CYANIDANOL-3 1 (+)-EPIPINORESINOL 1 (+)-EUDESMA-4(14),7(11)-DIENE-3-ONE 1 (+)-GALBACIN 2 (+)-GALLOCATECHIN 3 (+)-HERNANDEZINE 1 (+)-ISOCORYDINE 2 (+)-PSEUDOEPHEDRINE 1 (+)-SYRINGARESINOL 1 (+)-SYRINGARESINOL-DI-O-BETA-D-GLUCOSIDE 2 (+)-T-CADINOL 1 (+)-VESTITONE 1 (-)-16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 (-)-3-HYDROXY-9-METHOXYPTEROCARPAN 1 (-)-ACANTHOCARPAN 1 (-)-ALPHA-BISABOLOL 2 (-)-ALPHA-HYDRASTINE 1 Chemical Activity Count (-)-APIOCARPIN 1 (-)-ARGEMONINE 1 (-)-BETONICINE 1 (-)-BISPARTHENOLIDINE 1 (-)-BORNYL-CAFFEATE 2 (-)-BORNYL-FERULATE 2 (-)-BORNYL-P-COUMARATE 2 (-)-CANESCACARPIN 1 (-)-CENTROLOBINE 1 (-)-CLANDESTACARPIN 1 (-)-CRISTACARPIN 1 (-)-DEMETHYLMEDICARPIN 1 (-)-DICENTRINE 1 (-)-DOLICHIN-A 1 (-)-DOLICHIN-B 1 (-)-EPIAFZELECHIN 2 (-)-EPICATECHIN 6 (-)-EPICATECHIN-3-O-GALLATE 2 (-)-EPICATECHIN-GALLATE 1 (-)-EPIGALLOCATECHIN 4 (-)-EPIGALLOCATECHIN-3-O-GALLATE 1 (-)-EPIGALLOCATECHIN-GALLATE 9 (-)-EUDESMIN 1 (-)-GLYCEOCARPIN 1 (-)-GLYCEOFURAN 1 (-)-GLYCEOLLIN-I 1 (-)-GLYCEOLLIN-II 1 2 Chemical Activity Count (-)-GLYCEOLLIN-III 1 (-)-GLYCEOLLIN-IV 1 (-)-GLYCINOL 1 (-)-HYDROXYJASMONIC-ACID 1 (-)-ISOSATIVAN 1 (-)-JASMONIC-ACID 1 (-)-KAUR-16-EN-19-OIC-ACID 1 (-)-MEDICARPIN 1 (-)-VESTITOL 1 (-)-VESTITONE 1 -
A UHPLC-Q-Exactive-Orbitrap-MS Method for Simultaneous Determination of Three Flavonoids from Parasitic Loranthus and Their Pharmacokinetics in Rat Plasma
Cui et al Tropical Journal of Pharmaceutical Research October 2019; 18 (10): 2175-2182 ISSN: 1596-5996 (print); 1596-9827 (electronic) © Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria. Available online at http://www.tjpr.org http://dx.doi.org/10.4314/tjpr.v18i10.25 Original Research Article A UHPLC-Q-Exactive-Orbitrap-MS method for simultaneous determination of three flavonoids from Parasitic loranthus and their pharmacokinetics in rat plasma Ying Cui1,2, Lingling Li1,2*, Shu Yang1, Hongli Wang1, Jing Feng1, Kai Ma3, Deen Han1 1School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, 2Collaborative Innovation Center for Respiratory Disease Diagnosis and Treatment & Chinese Medicine Development of Henan Province, 156 Jinshui East Road, Zhengzhou 450046, 3Henan Province Chinese Medicine Research Institute, Zhengzhou, China *For correspondence: Email: [email protected], [email protected] Sent for review: 29 December 2018 Revised accepted: 18 September 2019 Abstract Purpose: To develop and validate a chromatographic method for the simultaneous determination of plasma levels of rutin, avicularin and quercitrin using UHPLC-Q-Exactive-Orbitrap-MS. Methods: A sensitive, selective, and reliable UHPLC-Q-Exactive-Orbitrap-MS method was developed and validated for simultaneous determination of the three flavonoids, with puerarin as internal standard (IS). Plasma samples were first treated with methanol, and then acidified using hydrochloric acid (HCl) prior to liquid-liquid extraction with ethyl acetate. The flavonoids were separated on a Syncronis C18 column (100×2.1mm, 1.7 µm) using an elution gradient of acetonitrile and 0.1 % formic acid at a flow rate of 0.3 mL/min. -
Flavonoids: a Review Application. Parti For
J. Appl. Cosmetol. 25, 93-709 (July/September 2007) FLAVONOIDS: A REVIEW FOR COSMETIC APPLICATION. PARTI Mrs.ir. Elzbieta E.Brand-Garnys ', Dr. Horst Denzer ', Dr. Hamke Meijer ', Dr.ir. Hans M.Brand ' ' ELZBIETA COSMETICS B.V., Nieuwerkerk a/d IJssel - The Netherlands ' KAO CHEMICALS GmbH, Emmerich - Germany Received: March, 2007. Key words: Bio-active substances; Biologico/ extracts; Enzyme monipulation; Enzyme cofoctor; Summary Flavonoids are now recognised as essential dietary components, although their functions are just on the brink of understanding. Dietary requirements have been establi shed. Their significance is proba bly equal to vitamins. Approximately 5000 flavonoids have been identified, and the list is quickly expanding. The functionality of flavonoids is frequently "multi-purpose", contrary to vitamins, enzy mes and (to a lesser extent) hormones. Riassunto I flavonoidi sono riconosciuti come componenti essenziali delle diete, anche se non sono state anco ra comprese appieno le loro funzioni. Comunque ne è stato riconosciuto il loro ruolo dietetico che dovrebbe essere simile a quello delle vitamine. Circa 5000 sono i flavonoidi già identificati ed il loro numero si incrementa di continuo. Al contra rio delle vitamine, degli enzimi e degli ormoni, l'attività di questi composti naturali è più complessa e serve a molteplici scopi. 93 Flavonoids: a Review far Cosmetic App/ication INTRODUCTION noi. The corresponding flavonoids may be for med from the chalcones via oxidative ring closu The Greek word "flava" means yellow. re. Also flavonoids are known that are formed by Flavonoids represent a broad variation of aroma reduction of the carbonyl group on the 4-posi tic compounds occurring in higher plants, fre tion.